EUVIMEDEUVIMED entdecken
Leitlinie

Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Megan E Daly, Navneet Singh iD, Nofisat Ismaila iD, Management of Stage III NSCLC Guideline Expert Panel

Journal of Clinical Oncology · 2024-09 · 42 (25) · 3058-3060

DOI: 10.1200/jco-24-01324 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Oncology, 2024-09. Verfasst von Megan E Daly und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of California Davis Comprehensive Cancer Center, Sacramento, CA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only) .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm StagingHumansMedical Oncology

Autor:innen und Institutionen

  • University of California Davis Comprehensive Cancer Center, Sacramento, CA.
  • Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • American Society of Clinical Oncology, Alexandria, VA.

ORCID-Profile: Navneet Singh, Nofisat Ismaila

Zitieren

APA

Daly, M. E., Singh, N., Ismaila, N., & Management of Stage III NSCLC Guideline Expert Panel (2024). Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology, 42(25), 3058-3060. https://doi.org/10.1200/jco-24-01324

Vancouver

Daly ME, Singh N, Ismaila N, Management of Stage III NSCLC Guideline Expert Panel. Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 2024;42(25):3058-3060. doi:10.1200/jco-24-01324

BibTeX
@article{Daly2024,
  author = {Daly, Megan E and Singh, Navneet and Ismaila, Nofisat and Management of Stage III NSCLC Guideline Expert Panel, Management of Stage III NSCLC Guideline Expert Panel},
  title = {Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {25},
  pages = {3058--3060},
  doi = {10.1200/jco-24-01324}
}
Kostenlos starten →